News
Reduction in immunotherapy treatment for skin cancer shows promise in clinical trial
Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control when compared to giving treatments over a longer period.
Leeds leads breakthrough in anal cancer treatment
A kinder treatment for anal cancer involving a lower dose and shorter course of radiotherapy is more effective than traditional treatment, a clinical trial led by Leeds researchers has found.
Extending blood cancer remission
An innovative blood cancer treatment regime could extend remission by seven months on average, according to a clinical trial led by the University of Leeds.
New immunotherapy trial for older colon cancer patients
Elderly colon cancer patients are being given the chance to access a clinical trial led by the University of Leeds that could transform future practice.
Professor Karen Spilsbury part of a £24m NIHR investment to tackle challenges facing NHS and care
Professor Karen Spilsbury has been awarded share of £24m NIHR funding to develop research to foster a more effective and well-supported social care workforce.